Preclinical and clinical evaluation of Siddha classical drug KARUNJEERAKA MATHIRAI (oral administration)along with application of NUNAA TAILAM(external) in the management of VITILIGO in children
Phase 2
Completed
- Conditions
- Vitiligo,
- Registration Number
- CTRI/2022/01/039863
- Lead Sponsor
- Dr S Surendar
- Brief Summary
It is a single arm trial for preclinical and clinical evaluation of effect on oral administration of KARUNJEERAKA MATHIRAI along with external application of NUNAA TAILAM in the management of VENPADAI in children
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1.Hypo pigemented patches surrounded by hyper pigemneted border present in any part of the body.
Exclusion Criteria
1.Children above 12 years 2.Children below 3 years 3.Albinism 4.Pie-baldism 5.Hypo pigmented patches start firstly in lips and genital area 6.Depigemented patches after burns 7.Juvenile diabetes with vitiligo.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in clinical symptoms 45 days Reduction in clinical symptoms 45 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Government Siddha Medical College and Hospital Palyamkottai
🇮🇳Tirunelveli, TAMIL NADU, India
Government Siddha Medical College and Hospital Palyamkottai🇮🇳Tirunelveli, TAMIL NADU, IndiaDr S SurendarPrincipal investigator7010482698surendarbsms20@gmail.com